GenMont Biotech Incorporation (TPE:3164)
Taiwan · Delayed Price · Currency is TWD 17.75
+0.05 (0.28%)
At close: Feb 11, 2026
TPE:3164 Market Cap
TPE:3164 has a market cap or net worth of 1.53 billion as of February 11, 2026. Its market cap has decreased by -9.27% in one year.
Market Cap
1.53B
Enterprise Value
1.43B
Revenue
391.48M
Ranking
n/a
PE Ratio
45.52
Stock Price
17.75
Market Cap Chart
Since May 8, 2006, TPE:3164's market cap has increased from 899.18M to 1.53B, an increase of 69.79%. That is a compound annual growth rate of 2.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.53B | -3.27% |
| Dec 31, 2025 | 1.58B | -9.68% |
| Dec 31, 2024 | 1.75B | -18.22% |
| Dec 29, 2023 | 2.14B | 4.39% |
| Dec 30, 2022 | 2.05B | -2.67% |
| Dec 30, 2021 | 2.10B | 9.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chunghwa Chemical Synthesis & Biotech | 1.98B |
| Advagene Biopharma | 1.89B |
| Genomics BioSci & Tech. | 1.78B |
| NeoCore Technology | 1.54B |
| Abnova (Taiwan) | 1.53B |
| Great Novel Therapeutics Biotech & Medicals | 1.44B |
| Enimmune | 1.43B |
| Meribank Biotech | 1.30B |